ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock
$88,71
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 4, 2026
52W-Spanne
$19–$95
91% of range
Analystenbewertung
BUY
20 analysts
Kursziel
$110
+24% upside
P/E (TTM)
-9362.7
ROE
-0.50%
Nettogewinnmarge
-0.20%
Über Arrowhead Pharmaceuticals, Inc. - Common Stock Unternehmensübersicht von Wikipedia
ARWR Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$88.70
Marktkapitalisierung
$12.71B
P/E (TTM)
-9362.7
EPS (TTM)
$-0.01
Umsatz (TTM)
$829M
Dividendenrendite
—
ROE
-0.50%
Verschuldungsgrad
—
52W-Spanne
$19 – $95
ARWR Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$829M
2016-09-30
→
2025-09-30
EPS
$-0.01
2017-09-30
→
2025-09-30
Freier Cashflow
$157M
2016-09-30
→
2025-09-30
Margen
-0.20%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
ARWR
Peer-Median
P/E (TTM)
-9362.7
28.5
P/S (TTM) (K/V (TTM))
15.3
20.1
P/B (K/B)
27.3
12.9
Price / FCF (Kurs / FCF)
81.0
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
ARWR
Peer-Median
Operating Margin (Betriebsgewinnmarge)
11.9%
—
Net Profit Margin (Nettogewinnmarge)
-0.20%
-48.4%
ROA
-0.13%
-28.4%
ROE
-0.50%
-49.2%
ROIC
12.3%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
ARWR
Peer-Median
Current Ratio (Liquiditätsgrad)
4.9
5.0
Quick Ratio
0.0
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
ARWR
Peer-Median
Revenue YoY (Umsatz YoY)
23258.2%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
50.5%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
56.6%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
ARWR
Peer-Median
ARWR Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
20 Analysten
- Starker Kauf 6 30,0%
- Kauf 13 65,0%
- Halten 1 5,0%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
11 Analysten · 2026-08-17
Median
$104.00
Mittelwert
$110.18
← Unter allen Zielen
$88.70
Tief
$100.00
Hoch
$126.00
Median-Ziel
$104.00
+17,2%
Mittelwert-Ziel
$110.18
+24,2%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.51%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-1.36 | $-1.35 | -0.01% |
| 31. März 2026 | $-0.93 | $-1.21 | 0.28% |
| 31. Dezember 2025 | $0.22 | $0.26 | -0.04% |
| 30. September 2025 | $-0.18 | $-0.25 | 0.07% |
| 30. Juni 2025 | $-1.26 | $-1.05 | -0.21% |
| 31. März 2025 | $2.75 | $-0.20 | 3.0% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ARWR | $4.68B | -3449.0 | 23258.2% | -0.20% | -0.50% | — |
| NBIX | $14.20B | 30.4 | 21.4% | 16.7% | 16.1% | — |
| BBIO | $14.90B | -20.2 | 126.3% | -146.0% | 41.2% | — |
| BMRN | $11.43B | 33.0 | 12.9% | 10.8% | 5.8% | — |
| EXEL | $11.44B | 15.7 | 7.0% | 33.7% | 37.3% | — |
| MDGL | $13.30B | -45.3 | 432.1% | -30.1% | -44.4% | — |
| HALO | $7.93B | 26.3 | 37.5% | 22.7% | 166.1% | — |
| PRAX | $7.43B | -21.9 | 249.5% | — | -47.3% | — |
| CYTK | $7.81B | -9.7 | 376.6% | -891.6% | 152.7% | — |
| APGE | $5.16B | -17.9 | — | — | — | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $829M | $4M | $241M | $243M | $138M | $88M | $169M | $16M | $31M | $158.3K | $382.0K | $175.0K | |
| R&D Expense | $607M | $506M | $353M | · | · | · | · | · | · | · | $47M | $23M | |
| SG&A Expense | $124M | $99M | $93M | $124M | $81M | $52M | $27M | $19M | $17M | $24M | $8M | $6M | |
| Operating Expenses | $731M | $605M | $446M | $422M | $287M | $181M | $108M | $72M | $68M | $82M | $96M | $53M | |
| Operating Income | $98M | $-601M | $-205M | $-179M | $-149M | $-93M | $61M | $-56M | $-37M | $-82M | $-96M | $-53M | |
| Interest Expense | · | · | $18M | $0 | $0 | · | · | · | · | · | · | · | |
| Other Non-op | $5M | $-2M | $2M | $765.0K | $2M | $-583.0K | · | $7.5K | $1M | $57.4K | $417.9K | $82.1K | |
| Pretax Income | $52M | $-612M | $-206M | $-173M | $-141M | $-85M | $68M | $-54M | $-34M | $-82M | $-92M | $-59M | |
| Income Tax | $21M | $-3M | $3M | $4M | $2.0K | $2.0K | $174.0K | $2.4K | $2.4K | $2.4K | $2.4K | $5.3K | |
| Net Income | $-2M | $-599M | $-205M | $-176M | $-141M | $-85M | $68M | $-54M | $-34M | $-82M | $-92M | $-59M | |
| EPS (Basic) | $-0.01 | $-5.00 | $-1.92 | $-1.67 | $-1.36 | $-0.84 | $0.72 | $-0.65 | $-0.47 | · | · | · | |
| EPS (Diluted) | $-0.01 | $-5.00 | $-1.92 | $-1.67 | $-1.36 | $-0.84 | $0.69 | $-0.65 | $-0.47 | · | · | · | |
| Shares (Basic) | 133,758,000 | 119,784,000 | 106,750,000 | 105,426,000 | 103,745,000 | 100,722,000 | 93,859,000 | 83,638,469 | 73,898,598 | · | · | · | |
| Shares (Diluted) | 133,758,000 | 119,784,000 | 106,750,000 | 105,426,000 | 103,745,000 | 100,722,000 | 98,608,000 | 83,638,469 | 73,898,598 | · | · | · | |
| EBITDA | $121M | · | $-194M | $-170M | $-142M | $-89M | $64M | $-56M | $-37M | $-82M | $-96M | $-52M |
Bilanz 27
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | $184M | $144M | $222M | $30M | $25M | $85M | $81M | $133M | |
| Short-term Investments | $693M | · | · | $0 | $127M | $85M | · | · | · | · | · | $22M | |
| Receivables | $7M | $0 | $0 | $1M | $10M | $846.0K | $661.4K | $327.4K | $67.8K | $75.0K | · | · | |
| Prepaid Expense | $11M | $10M | $9M | $7M | $4M | $4M | $3M | $1M | $867.4K | $1M | $3M | $588.6K | |
| Other Current Assets | $14M | $5M | $4M | $20M | $2M | $2M | $3M | $640.1K | $1M | $4M | $823.6K | $48.5K | |
| Current Assets | $951M | $695M | $416M | $405M | $385M | $322M | $265M | $79M | $68M | $91M | $103M | $155M | |
| PP&E (Net) | $383M | $386M | $290M | $110M | $49M | $31M | $23M | $14M | $16M | $15M | $5M | $4M | |
| PP&E (Gross) | $463M | $444M | $332M | $142M | $72M | $47M | $35M | $24M | $23M | $20M | $10M | $8M | |
| Accum. Depreciation | $80M | $58M | $42M | $32M | $23M | $16M | $12M | $10M | $7M | $5M | $5M | $4M | |
| Intangibles | $7M | $9M | $10M | $12M | $14M | $15M | $17M | $19M | $20M | $22M | $25M | $1M | |
| Other Non-current Assets | $1M | $4M | $3M | $218.0K | $272.0K | $264.0K | $144.1K | $141.9K | $141.9K | $122.3K | $45.8K | · | |
| Total Assets | $1.39B | $1.14B | $766M | $692M | $710M | $523M | $350M | $112M | $104M | $128M | $132M | $183M | |
| Accounts Payable | $18M | $11M | $36M | $3M | $9M | $7M | $8M | $3M | $4M | $12M | $5M | $3M | |
| Accrued Liabilities | $90M | $63M | $40M | $47M | $14M | $5M | $7M | $5M | $5M | $5M | $5M | $1M | |
| Short-term Debt | · | · | · | · | · | · | · | $223.8K | $208.5K | $194.3K | · | $50.0K | |
| Current Liabilities | $195M | $103M | $105M | $139M | $147M | $41M | $97M | $12M | $19M | $26M | $16M | $12M | |
| Capital Leases | $104M | $111M | $105M | $79M | $23M | $20M | · | · | · | · | $540.8K | $758.3K | |
| Other Non-current Liabilities | · | · | · | $0 | · | · | · | $200.0K | $200.0K | $200.0K | $200.0K | $255.2K | |
| Total Debt | · | · | · | · | · | · | · | $223.8K | $208.5K | $194.3K | · | $50.0K | |
| Common Stock | $231.0K | $217.0K | $200.0K | $198.0K | $197.0K | $195.0K | $187.9K | $180.9K | $167.2K | $162.1K | $151.9K | $147.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | $583M | $514M | $494M | $427M | $391M | |
| Retained Earnings | $-1.63B | $-1.63B | $-1.03B | $-821M | $-645M | $-504M | $-419M | $-487M | $-433M | $-398M | $-317M | $-225M | |
| Treasury Stock | $53M | $0 | · | · | · | · | · | · | · | · | · | · | |
| AOCI | $6M | $5M | $-3M | $-136.0K | $-69.0K | $18.0K | $-391.6K | $-21.6K | $33.2K | $7.4K | $-136.4K | · | |
| Stockholders' Equity | $466M | $185M | $271M | $399M | $409M | $462M | $244M | $95M | $81M | $96M | $110M | $167M | |
| Liabilities + Equity | $1.39B | $1.14B | $766M | $692M | $710M | $523M | $350M | $112M | $104M | $128M | $132M | $183M | |
| Shares Outstanding | 135,702,000 | 124,376,000 | 107,312,000 | 105,960,000 | 104,327,000 | 102,376,000 | 95,506,271 | 88,505,302 | 74,785,726 | 69,746,685 | 59,544,677 | 54,656,936 |
Cashflow 15
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $22M | $17M | $11M | $9M | $7M | $4M | $3M | $3M | $3M | $3M | $2M | $1M | |
| Stock-based Comp | $63M | $74M | $78M | $121M | $77M | $43M | $12M | $8M | $8M | $12M | $10M | $6M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $54.7K | |
| Other Non-cash | $96M | · | $-37M | $-90M | $229M | $-58M | $90M | · | · | · | · | $16M | |
| Operating Cash Flow | $180M | $-463M | $-154M | $-136M | $171M | $-96M | $173M | $-47M | $-24M | $-64M | $-66M | $-35M | |
| CapEx | $23M | $141M | $177M | $53M | $24M | $12M | $12M | $1M | $8M | $4M | $2M | $2M | |
| Investing Cash Flow | $-129M | $-420M | $-96M | $-5M | $-142M | $-241M | $-48M | $-7M | $-49M | $13M | · | · | |
| Stock Issued | $241M | $429M | $0 | $0 | $0 | $250M | $61M | $57M | $12M | $52M | · | $173M | |
| Net Stock Activity | $241M | · | · | $0 | · | $250M | $61M | $57M | $12M | $52M | · | · | |
| Financing Cash Flow | $74M | $871M | $253M | $65M | $11M | $258M | $66M | $60M | $12M | $55M | · | · | |
| Net Change in Cash | · | · | · | · | $41M | $-78M | $192M | $5M | $-61M | $4M | $-51M | $113M | |
| Taxes Paid | $814.0K | $-4M | $0 | $-2.0K | $-2.0K | $103.0K | $-302.0K | $-2.4K | · | · | · | · | |
| Free Cash Flow | $157M | · | $-331M | $-189M | $148M | $-107M | $161M | $-49M | $-32M | $-68M | $-68M | $-37M | |
| Levered FCF | · | · | $-349M | · | · | · | · | · | · | · | · | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.9% | · | -85.2% | -73.4% | -107.8% | -105.9% | 36.2% | -346.5% | -117.8% | -51627.1% | -25124.1% | -30443.6% | |
| Net Margin | -0.20% | · | -85.3% | -72.4% | -101.8% | -96.1% | 40.3% | -337.3% | · | -51614.6% | -24068.3% | -33503.0% | |
| Pretax Margin | 6.2% | · | -85.8% | -71.0% | -101.8% | -96.1% | 40.4% | -337.3% | -109.5% | -51613.1% | -24067.7% | -33554.3% | |
| EBITDA Margin | 14.5% | · | -80.7% | -69.8% | -103.0% | -101.0% | 37.9% | -346.5% | -117.8% | -51627.1% | -25124.1% | -29674.7% | |
| ROA | -0.13% | · | -28.2% | -25.1% | -22.9% | -19.4% | 29.5% | -50.5% | · | -62.8% | -58.4% | -53.3% | |
| ROE | -0.50% | · | -61.3% | -45.7% | -33.0% | -17.7% | 40.0% | -61.5% | · | -79.4% | -66.5% | -60.4% | |
| ROIC | 12.3% | · | -76.6% | -45.8% | -36.5% | -20.2% | 24.9% | -58.3% | -45.3% | -85.4% | -87.1% | -32.0% |
Liquidität & Solvenz 4
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.9 | · | 4.0 | 2.9 | 2.6 | 7.9 | 2.7 | 6.4 | 3.6 | 3.5 | 6.5 | 13.1 | |
| Quick Ratio | 0.0 | · | 0.0 | 0.0 | 2.2 | 5.6 | 2.3 | 2.5 | 1.3 | 3.3 | 5.1 | 13.0 | |
| Debt / Equity | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Interest Coverage | · | · | -11.2 | · | · | · | · | · | · | · | · | · |
Effizienz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | · | 0.3 | 0.3 | 0.2 | 0.2 | 0.7 | 0.1 | 0.3 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | 243.1 | · | 341.5 | 41.7 | 24.9 | 116.8 | 341.4 | 81.7 | 439.9 | 2.1 | · | · |
Wachstumsraten 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 23258.2% | -98.5% | -1.0% | 75.9% | 57.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 50.5% | -70.5% | 39.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 56.6% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $829M | $4M | $241M | $243M | $138M | $88M | $169M | $16M | $31M | $158.3K | $382.0K | $175.0K | |
| Net Income TTM | $-2M | $-599M | $-205M | $-176M | $-141M | $-85M | $68M | $-54M | $-34M | $-82M | $-92M | $-59M | |
| Market Cap | $4.68B | · | $2.88B | $3.50B | $6.51B | $4.41B | $2.69B | $1.70B | $324M | $513M | $343M | $807M | |
| Enterprise Value | · | · | · | · | · | · | · | $1.67B | $299M | $427M | · | $653M | |
| P/E | -3449.0 | -3.9 | -14.0 | -19.8 | -45.9 | -51.3 | 40.8 | -29.5 | -9.2 | · | · | · | |
| P/S | 5.6 | · | 12.0 | 14.4 | 47.1 | 50.1 | 15.9 | 105.1 | 10.3 | 3237.7 | 897.8 | 4613.0 | |
| P/B | 10.0 | · | 10.6 | 8.8 | 15.9 | 9.5 | 11.0 | 17.7 | 4.0 | 5.4 | 3.1 | 4.8 | |
| P / Tangible Book | 10.2 | 13.6 | 11.0 | 9.1 | 16.5 | 9.9 | · | · | · | · | · | · | |
| P / Cash Flow | 26.1 | · | -18.7 | -25.7 | 38.0 | -46.2 | 15.6 | -35.9 | -13.5 | -8.0 | -5.2 | -22.8 | |
| P / FCF | 29.8 | · | -8.7 | -18.5 | 44.1 | -41.1 | 16.7 | -34.9 | -10.2 | -7.5 | -5.1 | -21.7 | |
| EV / EBITDA | · | · | · | · | · | · | · | -29.8 | -8.1 | -5.2 | · | -12.6 | |
| EV / FCF | · | · | · | · | · | · | · | -34.3 | -9.4 | -6.3 | · | -17.6 | |
| EV / Revenue | · | · | · | · | · | · | · | 103.3 | 9.5 | 2699.8 | · | 3732.4 | |
| Earnings Yield | -0.03% | -25.8% | -7.1% | -5.1% | -2.2% | -1.9% | 2.5% | -3.4% | -10.8% | · | · | · |
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $75M | $74M | $264M | $256M | $28M | $543M | $2M | $0 | $0 | $0 | $4M | $16M | $16M | $146M | $63M | $32M | |
| R&D Expense | $198M | $173M | $177M | $175M | $162M | $133M | $137M | · | · | · | · | · | · | · | · | · | |
| SG&A Expense | $47M | $42M | $46M | $38M | $31M | $28M | $27M | $26M | $24M | $25M | $24M | $25M | $24M | $23M | $21M | $32M | |
| Operating Expenses | $245M | $215M | $223M | $212M | $193M | $162M | $164M | $162M | $176M | $126M | $140M | $124M | $119M | $98M | $105M | $115M | |
| Operating Income | $-170M | $-141M | $41M | $44M | $-166M | $381M | $-161M | $-162M | $-176M | $-126M | $-137M | $-108M | $-103M | $48M | $-42M | $-84M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $7M | $5M | · | $5M | $5M | $3M | · | |
| Other Non-op | $1M | $-2M | $277.0K | $5M | $-176.0K | $438.0K | $341.0K | $-3M | $760.0K | $189.0K | $421.0K | $717.0K | $306.0K | $8.0K | $507.0K | $90.0K | |
| Pretax Income | $-179M | $-138M | $28M | $36M | $-179M | $370M | $-175M | $-173M | $-174M | $-127M | $-139M | $-109M | $-103M | $48M | $-42M | $-82M | |
| Income Tax | $11.0K | $7.0K | $29.0K | $20M | $-437.0K | $2M | $103.0K | $546.0K | $0 | $0 | $-3M | $2M | $742.0K | $0 | $17.0K | $4M | |
| Net Income | $-194M | $-133M | $31M | $-24M | $-175M | $370M | $-173M | $-171M | $-171M | $-125M | $-133M | $-110M | $-103M | $49M | $-41M | $-86M | |
| EPS (Basic) | $-1.36 | $-0.93 | $0.22 | $-0.14 | $-1.26 | $2.78 | $-1.39 | $-1.36 | $-1.38 | $-1.02 | $-1.24 | $-1.03 | $-0.96 | $0.46 | $-0.39 | $-0.81 | |
| EPS (Diluted) | $-1.36 | $-0.93 | $0.22 | $-0.11 | $-1.26 | $2.75 | $-1.39 | $-1.36 | $-1.38 | $-1.02 | $-1.24 | $-1.02 | $-0.96 | $0.45 | $-0.39 | $-0.80 | |
| Shares (Basic) | 143,378,000 | 142,417,000 | 137,039,000 | -263,492,000 | 139,039,000 | 133,363,000 | 124,848,000 | -235,115,000 | 124,199,000 | 123,285,000 | 107,415,000 | -213,050,000 | 107,004,000 | 106,757,000 | 106,039,000 | -210,406,000 | |
| Shares (Diluted) | 143,378,000 | 142,417,000 | 140,706,000 | -264,613,000 | 139,039,000 | 134,484,000 | 124,848,000 | -235,115,000 | 124,199,000 | 123,285,000 | 107,415,000 | -214,436,000 | 107,004,000 | 108,143,000 | 106,039,000 | -212,790,000 | |
| EBITDA | $-164M | $-135M | $47M | · | $-160M | $387M | $-157M | · | $-172M | $-122M | $-133M | · | $-100M | $50M | $-40M | · |
Bilanz 24
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | · | · | $69M | $128M | $58M | · | $105M | $135M | $202M | · | |
| Short-term Investments | · | $1.60B | $715M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables | $9M | $16M | $219M | $7M | $10M | $2M | $2M | $0 | · | · | · | · | $1M | $69M | $40M | · | |
| Prepaid Expense | $25M | $22M | $16M | $11M | $24M | $24M | $9M | $10M | $9M | $11M | $11M | · | $10M | $10M | $8M | · | |
| Other Current Assets | $36M | $18M | $23M | $14M | $13M | $12M | $6M | $5M | $4M | $8M | $7M | · | $7M | $14M | $25M | · | |
| Current Assets | $1.67B | $1.84B | $1.17B | $951M | $947M | $1.14B | $571M | $695M | $450M | $542M | $238M | · | $470M | $575M | $575M | · | |
| PP&E (Net) | $373M | $375M | $379M | $383M | $381M | $385M | $387M | $386M | $376M | $359M | $333M | · | $231M | $185M | $147M | · | |
| PP&E (Gross) | $471M | $466M | $465M | $463M | $455M | $453M | $450M | $444M | $430M | $409M | $379M | · | $270M | $221M | $181M | · | |
| Accum. Depreciation | $97M | $91M | $86M | $80M | $74M | $68M | $63M | $58M | $54M | $50M | $46M | · | $39M | $36M | $34M | · | |
| Intangibles | $6M | $6M | $6M | $7M | $7M | $8M | $8M | $9M | $9M | $9M | $10M | · | $11M | $11M | $12M | · | |
| Other Non-current Assets | $6M | $5M | $1M | $1M | $1M | $1M | $3M | $4M | $4M | $210.0K | $232.0K | · | $210.0K | $210.0K | $210.0K | · | |
| Total Assets | $2.11B | $2.27B | $1.60B | $1.39B | $1.38B | $1.57B | $1.01B | $1.14B | $884M | $955M | $626M | · | $796M | $891M | $891M | · | |
| Accounts Payable | $28M | $31M | $33M | $18M | $33M | $10M | $14M | $11M | $27M | $9M | $4M | · | $8M | $10M | $796.0K | · | |
| Accrued Liabilities | $86M | $77M | $130M | $90M | $65M | $78M | $59M | $63M | $48M | $37M | $47M | · | $38M | $40M | $48M | · | |
| Current Liabilities | $283M | $295M | $347M | $195M | $195M | $221M | $94M | $103M | $97M | $65M | $64M | · | $70M | $87M | $122M | · | |
| Capital Leases | $114M | $100M | $102M | $104M | $106M | $108M | $109M | $111M | $112M | $114M | $115M | · | $80M | $80M | $79M | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | $669.0K | · | · | · | |
| Common Stock | $237.0K | $236.0K | $233.0K | $231.0K | $230.0K | $230.0K | $218.0K | $217.0K | $217.0K | $217.0K | $200.0K | · | $199.0K | $199.0K | $199.0K | · | |
| Retained Earnings | $-1.92B | $-1.73B | $-1.60B | $-1.63B | $-1.60B | $-1.43B | $-1.80B | $-1.63B | $-1.45B | $-1.28B | $-1.16B | · | $-916M | $-813M | $-862M | · | |
| Treasury Stock | $53M | $53M | $53M | $53M | · | · | · | $0 | · | · | · | · | · | · | · | · | |
| AOCI | $-1M | $742.0K | $7M | $6M | $5M | $4M | $4M | $5M | $-987.0K | $-1M | $-1M | · | $-411.0K | $-332.0K | $-258.0K | · | |
| Stockholders' Equity | $466M | $614M | $568M | $466M | $522M | $683M | $53M | $185M | $331M | $484M | $160M | · | $365M | $447M | $377M | · | |
| Liabilities + Equity | $2.11B | $2.27B | $1.60B | $1.39B | $1.38B | $1.57B | $1.01B | $1.14B | $884M | $955M | $626M | · | $796M | $891M | $891M | · | |
| Shares Outstanding | 141,135,000 | 140,571,000 | 137,391,000 | 135,702,000 | 138,144,000 | 138,062,000 | 125,572,000 | 124,376,000 | 124,227,000 | 124,133,000 | 107,500,000 | 107,312,000 | 107,102,000 | 106,869,000 | 106,140,000 | · |
Cashflow 14
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $5M | $4M | $4M | $4M | $3M | $3M | $2M | $2M | $2M | |
| Stock-based Comp | $15M | $17M | $19M | $19M | $13M | $16M | $15M | $19M | $17M | $18M | $20M | $18M | $20M | $21M | $19M | $29M | |
| Amort. of Intangibles | $400.0K | $400.0K | $400.0K | $500.0K | $400.0K | $400.0K | $400.0K | $500.0K | $400.0K | $400.0K | $400.0K | $500.0K | $400.0K | $400.0K | $400.0K | $500.0K | |
| Other Non-cash | · | · | $-43M | · | · | · | $7M | · | · | · | $-8M | · | · | · | $-56M | · | |
| Operating Cash Flow | $-177M | $84M | $13M | $20M | $-155M | $460M | $-146M | $-137M | $-115M | $-92M | $-118M | $-26M | $-21M | $-32M | $-76M | $-69M | |
| CapEx | $4M | $3M | $2M | $7M | $2M | $5M | $8M | $24M | $14M | $34M | $69M | $64M | $47M | $27M | $39M | $33M | |
| Investing Cash Flow | $44M | $-894M | $-24M | $73M | $141M | $-420M | $77M | $-223M | $7M | $-269M | $65M | $31M | $-10M | $-36M | $-81M | $36M | |
| Stock Issued | · | · | $47M | $0 | $0 | $241M | $0 | $0 | $0 | · | · | $0 | $0 | · | · | · | |
| Net Stock Activity | · | · | $47M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-449.0K | $796M | $-15M | $4M | $-43M | $92M | $21M | $389M | $50M | $431M | $267.0K | $821.0K | $1M | $520.0K | $251M | $855.0K | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | · | · | · | $-30M | $-67M | $94M | · | |
| Taxes Paid | $22.0K | $12M | $10M | $733.0K | $0 | $92.0K | $11.0K | $-7M | $6M | $4M | $-999.0K | $0 | $0 | $0 | $0 | $-2.0K | |
| Free Cash Flow | · | · | $11M | · | · | · | $-154M | · | · | · | $-186M | · | · | · | $-114M | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | $-192M | · | · | · | · | · |
Rentabilität 7
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -226.0% | -191.6% | 15.5% | · | -596.2% | 70.2% | -6456.5% | · | · | · | -3845.2% | · | -649.0% | 32.9% | -67.4% | · | |
| Net Margin | -258.2% | -180.0% | 11.7% | · | -631.1% | 68.3% | -6923.4% | · | · | · | -3741.6% | · | -650.5% | 33.3% | -66.1% | · | |
| Pretax Margin | -237.7% | -186.6% | 10.7% | · | -645.0% | 68.1% | -7004.6% | · | · | · | -3905.6% | · | -653.3% | 32.6% | -66.8% | · | |
| EBITDA Margin | -217.8% | -183.6% | 17.7% | · | -575.3% | 71.3% | -6264.5% | · | · | · | -3738.2% | · | -630.7% | 34.4% | -63.7% | · | |
| ROA | -11.1% | -6.9% | 2.4% | · | -15.5% | 29.3% | -21.1% | · | -20.3% | -13.6% | -17.5% | · | -13.3% | 6.1% | -5.4% | · | |
| ROE | -39.3% | -20.5% | 9.9% | · | -41.1% | 63.5% | -162.5% | · | -49.1% | -26.9% | -49.4% | · | -25.1% | 10.8% | -11.0% | · | |
| ROIC | -36.5% | -23.0% | 7.2% | · | -31.6% | 55.5% | -307.1% | · | -53.3% | -26.1% | -83.1% | · | -28.3% | 10.8% | -11.2% | · |
Liquidität & Solvenz 3
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.9 | 6.2 | 3.4 | · | 4.9 | 5.1 | 6.1 | · | 4.7 | 8.3 | 3.7 | · | 6.7 | 6.6 | 4.7 | · | |
| Quick Ratio | 0.0 | 5.5 | 2.7 | · | 0.0 | 0.0 | 0.0 | · | 0.7 | 2.0 | 0.9 | · | 1.5 | 2.3 | 2.0 | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -17.4 | -25.4 | · | -19.9 | 9.5 | · | · |
Effizienz 2
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.2 | · | 0.0 | 0.4 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.2 | 0.1 | · | |
| Receivables Turnover | 8.2 | 8.2 | 2.4 | · | 5.1 | 15.1 | 0.1 | · | · | · | · | · | 21.3 | 4.1 | 3.1 | · |
Bewertung (TTM) 10
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $441M | $908M | $837M | · | $573M | $545M | $6M | · | $19M | $166M | $228M | · | $257M | $393M | $274M | · | |
| Net Income TTM | $-471M | $93M | $53M | · | $-149M | $-99M | $-602M | · | $-532M | $-312M | $-228M | · | $-168M | $-20M | $-132M | · | |
| Market Cap | $11.50B | $8.81B | $9.12B | · | $2.18B | $1.76B | $2.36B | · | $3.23B | $3.55B | $3.29B | · | $3.82B | $2.71B | $4.31B | · | |
| P/E | -24.5 | 80.4 | 207.5 | · | -12.3 | -12.2 | -3.7 | · | -5.7 | -10.3 | -14.3 | · | -22.6 | -121.0 | -32.2 | · | |
| P/S | 26.1 | 9.7 | 10.9 | · | 3.8 | 3.2 | 390.1 | · | 166.6 | 21.4 | 14.4 | · | 14.9 | 6.9 | 15.7 | · | |
| P/B | 24.7 | 14.4 | 16.0 | · | 4.2 | 2.6 | 44.9 | · | 9.8 | 7.3 | 20.5 | · | 10.5 | 6.1 | 11.4 | · | |
| P / Tangible Book | 25.0 | 14.5 | 16.2 | · | 4.2 | 2.6 | 53.1 | · | 10.0 | 7.5 | 21.8 | · | 10.8 | 6.2 | 11.8 | · | |
| P / Cash Flow | · | · | 676.6 | · | · | · | -16.1 | · | · | · | -27.9 | · | · | · | -57.0 | · | |
| P / FCF | · | · | 804.9 | · | · | · | -15.4 | · | · | · | -17.6 | · | · | · | -37.6 | · | |
| Earnings Yield | -4.1% | 1.2% | 0.48% | · | -8.1% | -8.2% | -26.8% | · | -17.7% | -9.7% | -7.0% | · | -4.4% | -0.83% | -3.1% | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| Umsatz | $829M | $4M | $241M | $243M | $138M |
| Betriebsgewinnmarge % | 11.9% | — | -85.2% | -73.4% | -107.8% |
| Nettoergebnis | $-2M | $-599M | $-205M | $-176M | $-141M |
| Verwässerte EPS | $-0.01 | $-5.00 | $-1.92 | $-1.67 | $-1.36 |
Bilanz
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 4.9 | — | 4.0 | 2.9 | 2.6 |
| Quick Ratio | 0.0 | — | 0.0 | 0.0 | 2.2 |
Cashflow
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| Freier Cashflow | $157M | — | $-331M | $-189M | $148M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 534 Einreicher · $7.8B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 129 (+17 vs. Vorquartal) | 54 (-1 vs. Vorquartal) | 150 (-3 vs. Vorquartal) | 159 (+27 vs. Vorquartal) | +18.3M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $940.062.881 | 14.159.706 | 11,99% | Aktien |
| Avoro Capital Advisors LLC | $925.591.288 | 11.355.555 | 11,80% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $517.698.946 | 6.351.355 | 6,60% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $498.103.779 | 6.110.953 | 6,35% | Aktien |
| STATE STREET CORP | $464.170.106 | 5.694.640 | 5,92% | Aktien |
| FMR LLC | $392.073.778 | 4.810.131 | 5,00% | Aktien |
| NORGES BANK | $317.606.649 | 3.896.536 | 4,05% | Aktien |
| FRED ALGER MANAGEMENT, LLC | $269.139.418 | 3.301.919 | 3,43% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $254.549.119 | 2.987.563 | 3,25% | Aktien |
| BAKER BROS. ADVISORS LP | $162.431.742 | 1.992.783 | 2,07% | Aktien |
| Siren, L.L.C. | $139.828.449 | 1.715.476 | 1,78% | Aktien |
| Vestal Point Capital, LP | $128.378.250 | 1.575.000 | 1,64% | Aktien |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $113.221.873 | 1.389.055 | 1,44% | Aktien |
| FIRST TRUST ADVISORS LP | $110.276.346 | 1.352.918 | 1,41% | Aktien |
| Driehaus Capital Management LLC | $110.083.820 | 1.350.556 | 1,40% | Aktien |
| Hood River Capital Management LLC | $91.352.088 | 1.120.747 | 1,16% | Aktien |
| Holocene Advisors, LP | $90.164.487 | 1.106.177 | 1,15% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $87.578.827 | 1.074.455 | 1,12% | Aktien |
| Fisher Asset Management, LLC | $78.061.392 | 957.691 | 1,00% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $75.309.290 | 923.927 | 0,96% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $73.093.114 | 896.738 | 0,93% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $70.718.076 | 867.600 | 0,90% | Kaufoption |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | $67.673.433 | 830.247 | 0,86% | Aktien |
| Western Financial Corp/CA | $66.857.681 | 820.239 | 0,85% | Aktien |
| GOLDMAN SACHS GROUP INC | $55.222.862 | 677.498 | 0,70% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $50.990.129 | 625.569 | 0,65% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48.626.665 | 596.573 | 0,62% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $47.325.440 | 580.609 | 0,60% | Aktien |
| Pictet Asset Management Holding SA | $46.708.118 | 573.419 | 0,60% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $45.534.991 | 558.643 | 0,58% | Aktien |
| 1832 Asset Management L.P. | $43.893.135 | 538.500 | 0,56% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $41.902.905 | 514.083 | 0,53% | Aktien |
| Balyasny Asset Management L.P. | $38.370.343 | 470.744 | 0,49% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $38.221.751 | 468.921 | 0,49% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $34.600.995 | 424.500 | 0,44% | Verkaufsoption |
| RHUMBLINE ADVISERS | $30.557.778 | 374.897 | 0,39% | Aktien |
| EVENTIDE ASSET MANAGEMENT, LLC | $30.158.700 | 370.000 | 0,38% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $29.687.001 | 364.211 | 0,38% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $26.844.259 | 329.337 | 0,34% | Aktien |
| Caption Management, LLC | $25.724.556 | 315.600 | 0,33% | Kaufoption |
| LPL Financial LLC | $25.330.147 | 310.761 | 0,32% | Aktien |
| Artisan Partners Limited Partnership | $25.325.646 | 310.706 | 0,32% | Aktien |
| CITADEL ADVISORS LLC | $21.755.019 | 266.900 | 0,28% | Kaufoption |
| BANK OF AMERICA CORP /DE/ | $21.066.994 | 258.459 | 0,27% | Aktien |
| California Public Employees Retirement System | $20.892.154 | 256.314 | 0,27% | Aktien |
| Squarepoint Ops LLC | $20.858.980 | 255.907 | 0,27% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $20.722.128 | 254.228 | 0,26% | Aktien |
| Aberdeen Group plc | $20.537.912 | 251.968 | 0,26% | Aktien |
| Swiss National Bank | $19.472.739 | 238.900 | 0,25% | Aktien |
| Privium Fund Management B.V. | $19.091.435 | 234.222 | 0,24% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $17.780.021 | 218.133 | 0,23% | Aktien |
| Life Cycle Investment Partners Ltd | $17.041.133 | 209.068 | 0,22% | Aktien |
| UBS Group AG | $16.742.806 | 205.408 | 0,21% | Aktien |
| Assenagon Asset Management S.A. | $16.459.070 | 201.927 | 0,21% | Aktien |
| Woodline Partners LP | $16.316.998 | 200.184 | 0,21% | Aktien |
| Integral Health Asset Management, LLC | $16.302.000 | 200.000 | 0,21% | Aktien |
| BlackRock, Inc. | $16.111.919 | 197.668 | 0,21% | Aktien |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | $15.603.622 | 191.432 | 0,20% | Aktien |
| PINNACLE ASSOCIATES LTD | $13.867.378 | 170.131 | 0,18% | Aktien |
| WCM INVESTMENT MANAGEMENT, LLC | $13.784.176 | 171.232 | 0,18% | Aktien |
| SEB Asset Management AB | $12.895.265 | 158.205 | 0,16% | Aktien |
| Clearbridge Investments, LLC | $12.806.043 | 157.110 | 0,16% | Aktien |
| Affinity Asset Advisors, LLC | $12.226.500 | 150.000 | 0,16% | Aktien |
| AMERIPRISE FINANCIAL INC | $12.132.846 | 148.851 | 0,15% | Aktien |
| WEALTH EFFECTS LLC | $12.006.423 | 147.300 | 0,15% | Aktien |
| Retirement Systems of Alabama | $11.874.947 | 145.687 | 0,15% | Aktien |
| HighTower Advisors, LLC | $11.443.515 | 140.394 | 0,15% | Aktien |
| JANE STREET GROUP, LLC | $11.134.266 | 136.600 | 0,14% | Kaufoption |
| Weiss Asset Management LP | $10.923.481 | 134.014 | 0,14% | Aktien |
| BANK OF NOVA SCOTIA | $10.906.451 | 133.805 | 0,14% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $10.863.716 | 173.265 | 0,14% | Aktien |
| PFM Health Sciences, LP | $10.732.177 | 131.667 | 0,14% | Aktien |
| Tetragon Partners GP Ltd | $10.635.751 | 130.484 | 0,14% | Aktien |
| JPMORGAN CHASE & CO | $10.476.675 | 130.145 | 0,13% | Aktien |
| Rhenman & Partners Asset Management AB | $10.433.280 | 128.000 | 0,13% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $9.708.004 | 119.102 | 0,12% | Aktien |
| Catalyst Funds Management Pty Ltd | $9.585.576 | 117.600 | 0,12% | Aktien |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $9.487.193 | 116.393 | 0,12% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $9.125.452 | 111.955 | 0,12% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $9.048.425 | 144.313 | 0,12% | Aktien |
| SEI INVESTMENTS CO | $8.993.976 | 110.342 | 0,11% | Aktien |
| ACT CAPITAL MANAGEMENT, LLC | $8.974.251 | 110.100 | 0,11% | Aktien |
| HSBC HOLDINGS PLC | $8.966.100 | 110.000 | 0,11% | Aktien |
| D. E. Shaw & Co., Inc. | $8.904.397 | 109.243 | 0,11% | Aktien |
| Empowered Funds, LLC | $8.806.422 | 108.041 | 0,11% | Aktien |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $8.503.286 | 104.322 | 0,11% | Aktien |
| Nuveen, LLC | $8.446.474 | 103.625 | 0,11% | Aktien |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $8.445.740 | 103.616 | 0,11% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $8.209.443 | 100.717 | 0,10% | Aktien |
| JANE STREET GROUP, LLC | $8.167.302 | 100.200 | 0,10% | Verkaufsoption |
| Ikarian Capital, LLC | $8.151.000 | 100.000 | 0,10% | Verkaufsoption |
| Dorsey Wright & Associates | $7.944.454 | 97.466 | 0,10% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $7.785.428 | 95.515 | 0,10% | Aktien |
| KEYSTONE INVESTORS PTE LTD | $7.715.818 | 94.661 | 0,10% | Aktien |
| Legal & General Group Plc | $7.248.684 | 88.930 | 0,09% | Aktien |
| JANE STREET GROUP, LLC | $7.194.154 | 88.261 | 0,09% | Aktien |
| Aquilo Capital Management, LLC | $7.008.656 | 550.130 | 0,09% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $6.828.256 | 83.772 | 0,09% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $6.374.082 | 78.200 | 0,08% | Kaufoption |
| Transamerica Financial Advisors, LLC | $6.309.121 | 77.403 | 0,08% | Aktien |
Unternehmensinsider 32 Insider · 16 Führungskräfte · 13 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Christopher Richard Anzalone | Chief Executive Officer | 20. Dezember 2022 A | 3.720.714 | 0 | 0 | $0 |
| Daniel Joseph Apel | Chief Financial Officer | 22. April 2026 S | 162.905 | 0 | 3 | $-934.286 |
| Kenneth Allen Myszkowski | Chief Financial Officer | 4. Januar 2023 A | 396.704 | 0 | 0 | $0 |
| McDonnel Paul Clayton | CFO (former) | 17. Juli 2009 J | — | 0 | 0 | $0 |
| Joseph Theodore Kingsley III | Chief Financial Officer | 29. März 2007 A | 12.000 | 0 | 0 | $0 |
| Leon Ekchian | President | 14. November 2005 A | — | 0 | 0 | $0 |
| Patrick O'Brien | COO and General Counsel | 5. Januar 2023 S | 413.375 | 0 | 0 | $0 |
| Bruce D Given | Chief Operating Officer | 28. April 2020 M | 850.730 | 0 | 0 | $0 |
| Tracie Oliver | Chief Commercial Officer | 4. Januar 2023 A | 70.500 | 0 | 0 | $0 |
| Javier San Martin | Chief Medical Officer | 4. Januar 2023 A | 151.500 | 0 | 0 | $0 |
| Curt Bradshaw | Chief Scientific Officer | 20. November 2020 S | 0 | 0 | 0 | $0 |
| Zhen Li | Snr. VP, Chem and Non-Clin Dev | 14. Januar 2019 S | 201.700 | 0 | 0 | $0 |
| Peter Brian Leone | VP, Strategic Bus. Initiatives | 19. Oktober 2018 M | 130.000 | 0 | 0 | $0 |
| David L. Lewis | Chief Scientific Officer | 1. Januar 2016 A | 0 | 0 | 0 | $0 |
| STEWART R BRUCE | Executive Chairman | 4. März 2010 A | 711.500 | 0 | 0 | $0 |
| James M Phillips JR | Secretary | 31. März 2004 A | — | 0 | 0 | $0 |
| Matthew Gregory Cohen | Direktor | 15. Juni 2026 A | 11.882 | 0 | 0 | $0 |
| Douglas S Ingram | Direktor | 16. Dezember 2025 A | 46.215 | 0 | 0 | $0 |
| Douglas B Given | Direktor | 27. Februar 2023 S | 13.000 | 0 | 0 | $0 |
| Victoria Vakiener | Direktor | 10. Januar 2023 A | 23.284 | 0 | 0 | $0 |
| Marianne De Backer | Direktor | 10. Januar 2023 A | 31.267 | 0 | 0 | $0 |
| William D. Waddill | Direktor | 10. Januar 2023 A | 36.817 | 0 | 0 | $0 |
| Mauro Ferrari | Direktor | 10. Januar 2023 A | 50.838 | 0 | 0 | $0 |
| Edward W Frykman | Direktor | 1. Januar 2018 A | 148.852 | 0 | 0 | $0 |
| Charles Mckenney | Direktor | 4. März 2015 A | 42.220 | 0 | 0 | $0 |
| Leroy T Rahn | Direktor | 4. März 2010 A | — | 0 | 0 | $0 |
| David M Knott | 10%-Eigentümer | 21. März 2007 S | 742.600 | 0 | 0 | $0 |
| Marshall Robert Ching | 10%-Eigentümer | 23. Juni 2005 U | 28.666 | 0 | 0 | $0 |
| Adeoye Y Olukotun | — | 19. Dezember 2025 S | 33.600 | 0 | 3 | $-676.623 |
| Michael S Perry | — | 16. Dezember 2025 A | 123.059 | 0 | 1 | $-991.738 |
| James C Hamilton | — | 5. Januar 2023 S | 191.484 | 0 | 0 | $0 |
| James Hassard | — | 22. Juni 2021 S | 105.750 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 3 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Sarepta Therapeutics, Inc., Sarepta Therapeutics Investments, Inc. ×2 Einreichungen | 15. August 2025 | 0,00% | Änderung | — | SEC |
| Silence Therapeutics Plc ×3 Einreichungen | 8. Dezember 2017 | — | Erste Einreichung | — | SEC |
| Novartis Institutes for BioMedical Research, Inc., Novartis AG ×2 Einreichungen | 28. November 2017 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 95 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IBRN · iShares Trust | 4,47% | 4.021 SH | 8. August 2026 | Täglich |
| GNOM · Global X Funds | 4,07% | 29.150 NS | 31. Mai 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 2,56% | 18.591 NS | 30. April 2026 | N-PORT |
| RFG · Invesco Exchange-Traded Fund Trust | 2,46% | 100.744 SH | 8. August 2026 | Täglich |
| XMMO · Invesco Exchange-Traded Fund Trust | 2,02% | 1.737.614 SH | 8. August 2026 | Täglich |
| PTH · Invesco Exchange-Traded Fund Trust | 2,01% | 56.530 SH | 8. August 2026 | Täglich |
| BBP · ETFis Series Trust I | 1,67% | 13.501 NS | 30. April 2026 | N-PORT |
| PDP · Invesco Exchange-Traded Fund Trust | 1,37% | 236.149 SH | 8. August 2026 | Täglich |
| LABU · Direxion Shares ETF Trust | 1,18% | 83.558 NS | 30. April 2026 | N-PORT |
| HRTS · Tema ETF Trust | 1,09% | 7.240 NS | 31. Mai 2026 | N-PORT |
| PAMC · Pacer Funds Trust | 0,88% | 7.520 NS | 30. April 2026 | N-PORT |
| IBB · iShares Trust | 0,88% | 971.687 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,84% | 7.664 SH | 8. August 2026 | Täglich |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,78% | 54.678 NS | 30. April 2026 | N-PORT |
| JSMD · Janus Detroit Street Trust | 0,71% | 95.209 NS | 30. April 2026 | N-PORT |
| FDMO · FIDELITY COVINGTON TRUST | 0,67% | 76.377 NS | 30. April 2026 | N-PORT |
| IJK · iShares Trust | 0,65% | 824.470 SH | 8. August 2026 | Täglich |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,60% | 138.986 SH | 8. August 2026 | Täglich |
| JSML · Janus Detroit Street Trust | 0,58% | 24.940 NS | 30. April 2026 | N-PORT |
| ABOT · Abacus FCF ETF Trust | 0,56% | 335 NS | 30. April 2026 | N-PORT |
| BIB · ProShares Trust | 0,55% | 5.178 NS | 31. Mai 2026 | N-PORT |
| MMSC · First Trust Exchange-Traded Fund VI… | 0,49% | 3.305 NS | 31. Mai 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,46% | 46.300 NS | 30. April 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,41% | 20.520 SH | 8. August 2026 | Täglich |
| XJH · iShares Trust | 0,38% | 19.017 SH | 8. August 2026 | Täglich |
| IQSM · New York Life Investments ETF Trust | 0,35% | 15.065 NS | 30. April 2026 | N-PORT |
| IJH · iShares Trust | 0,33% | 4.860.150 SH | 8. August 2026 | Täglich |
| BFOR · ALPS ETF Trust | 0,33% | 9.046 NS | 31. Mai 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,32% | 58.042 NS | 30. April 2026 | N-PORT |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,31% | 227.611 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,30% | 58.609 NS | 30. April 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,30% | 16.068 NS | 30. April 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,30% | 1.772.235 SH | 8. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,27% | 67.223 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,26% | 6.367 NS | 31. Mai 2026 | N-PORT |
| ABLS · Abacus FCF ETF Trust | 0,26% | 44 NS | 30. April 2026 | N-PORT |
| MVV · ProShares Trust | 0,24% | 4.843 NS | 31. Mai 2026 | N-PORT |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,23% | 18.551 NS | 30. April 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,23% | 673.375 NS | 31. Mai 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,23% | 15.031 NS | 30. April 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,22% | 70.532 NS | 30. April 2026 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0,22% | 18.456 NS | 30. April 2026 | N-PORT |
| ISCG · iShares Trust | 0,21% | 24.448 SH | 8. August 2026 | Täglich |
| IWP · iShares Trust | 0,21% | 490.695 SH | 8. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,20% | 67.415 SH | 8. August 2026 | Täglich |
| MIDU · Direxion Shares ETF Trust | 0,20% | 2.319 NS | 30. April 2026 | N-PORT |
| IYH · iShares Trust | 0,19% | 80.786 SH | 8. August 2026 | Täglich |
| UMDD · ProShares Trust | 0,17% | 676 NS | 31. Mai 2026 | N-PORT |
| ISCB · iShares Trust | 0,16% | 5.471 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,16% | 4.980 NS | 31. Mai 2026 | N-PORT |